Stimulation of erythrocyte cell membrane scrambling by amiodarone

Cellular Physiology and Biochemistry

Volumn 20, Issue 6, 2007, Pages 1043-1050

  Nicolay, Jan P ^a   Bentzen, Peter J ^a   Ghashghaeinia, Mehrdad ^a   Wieder, Thomas ^a   Lang, Florian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Annexin V; Apoptosis; Calcium; Ceramide; Channels

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTIBODY; CALCIUM CHANNEL; CALCIUM ION; CERAMIDE; CHLORIDE; FLUO 3; FLUORESCEIN ISOTHIOCYANATE; GLUCONIC ACID; HYPERTONIC SOLUTION; LIPOCORTIN 5; PHOSPHATIDYLSERINE; SUCROSE;

ARTICLE; CALCIUM CELL LEVEL; CELL DEATH; CELL VOLUME; CONTROLLED STUDY; CYTOSOL; DRUG ACTIVITY; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; ISOTOPE LABELING; PRIORITY JOURNAL;

AMIODARONE; ANNEXIN A5; CALCIUM SIGNALING; CERAMIDES; CHLORIDES; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMANS; OSMOTIC PRESSURE; PHOSPHATIDYLSERINES; VASODILATOR AGENTS;

EID: 35848958618     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000110713     Document Type: Article

References (49)

1. Lang KS, Lang PA, Bauer C, Duranton C, Wieder T, Huber SM, Lang F: Mechanisms of Suicidal Erythrocyte Death. Cell Physiol Biochem 2005;15:195-202.
2. Lang KS, Duranton C, Poehlmann H, Myssina S, Bauer C, Lang F, Wieder T, Huber SM: Cation channels trigger apoptotic death of erythorcytes. Cell Death Differ 2003;10:249-256.
3. Lang KS, Myssina S, Tanneur V, Wieder T, Huber SM, Lang F, Duranton C: Inhibition of erythrocyte cation channels and apoptosis by ethylisopropylamiloride. Naunyn Schmiedebergs Arch Pharmacol 2003;367:391-396.
4. Lang PA, Kempe DS, Akel A, Klarl BA, Eisele K, Podolski M, Hermle T, Niemoeller OM, Attanasio P, Huber SM, Wieder T, Lang F, Duranton C: Inhibition of erythrocyte "apoptosis" by catecholamines. Naunyn Schmiedebergs Arch Pharmacol 2005;372:228-235.
5. Lang PA, Kaiser S, Myssina S, Wieder T, Lang F, Huber SM: Role of Ca2+-activated K+ channels in human erythrocyte apoptosis. Am J Physiol Cell Physiol 2003;285:C1553-C1560.
6. Myssina S, Lang PA, Kempe DS, Kaiser S, Huber SM, Wieder T, Lang F: Clchannel blockers NPPB and niflumic acid blunt Ca(2+)-induced erythrocyte 'apoptosis'. Cell Physiol Biochem 2004;14:241-248.
7. Woon LA, Holland JW, Kable EP, Roufogalis BD: Ca2+ sensitivity of phospholipid scrambling in human red cell ghosts. Cell Calcium 1999;25:313-320.
8. Lang KS, Myssina S, Brand V, Sandu C, Lang PA, Berchtold S, Huber SM, Lang F, Wieder T: Involvement of ceramide in hyperosmotic shock-induced death of erythrocytes. Cell Death Differ 2004;11:231-243.
9. Boas FE, Forman L, Beutler E: Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proc Natl Acad Sci U S A 1998;95:3077-3081.
10. Kempe DS, Lang PA, Duranton C, Akel A, Lang KS, Huber SM, Wieder T, Lang F: Enhanced programmed cell death of iron-deficient erythrocytes. FASEB J 2006;20:368-370.
11. Lang KS, Roll B, Myssina S, Schittenhelm M, Scheel-Walter HG, Kanz L, Fritz J, Lang F, Huber SM, Wieder T: Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency. Cell Physiol Biochem 2002;12:365-372.
12. Birka C, Lang PA, Kempe DS, Hoefling L, Tanneur V, Duranton C, Nammi S, Henke G, Myssina S, Krikov M, Huber SM, Wieder T, Lang F: Enhanced susceptibility to erythrocyte "apoptosis" following phosphate depletion. Pflugers Arch 2004;448:471-477.
13. Lang PA, Beringer O, Nicolay JP, Amon O, Kempe DS, Hermle T, Attanasio P, Akel A, Schafer R, Friedrich B, Risler T, Baur M, Olbricht CJ, Zimmerhackl LB, Zipfel PF, Wieder T, Lang F: Suicidal death of erythrocytes in recurrent hemolytic uremic syndrome. J Mol Med 2006;84:378-388.
14. Kempe DS, Akel A, Lang PA, Hermle T, Biswas R, Muresanu J, Friedrich B, Dreischer P, Wolz C, Schumacher U, Peschel A, Gotz F, Doring G, Wieder T, Gulbins E, Lang F: Suicidal erythrocyte death in sepsis. J Mol Med 2007;85:269-77.
15. Brand VB, Sandu CD, Duranton C, Tanneur V, Lang KS, Huber SM, Lang F: Dependence of Plasmodium falciparum in vitro growth on the cation permeability of the human host erythrocyte. Cell Physiol Biochem 2003;13:347-356.
16. Lang PA, Schenck M, Nicolay JP, Becker JU, Kempe DS, Lupescu A, Eisele K, Klarl B, Ruebben H, Schmid KW, Mann K, Hildenbrand S, Huber SM, Wieder T, Erhardt A, Haeussinger D, Gulbins E, Lang F: Liver cell death and anemia in Wilson's disease involve acid sphingomyelinase and ceramide. Nat Med. 2007;13(2):164-70.
17. Nicolay JP, Schneider J, Niemoeller OM, Artunc F, Portero-Otin M, Haik G, Jr., Thornalley PJ, Schleicher E, Wieder T, Lang F: Stimulation of suicidal erythrocyte death by methylglyoxal. Cell Physiol Biochem 2006;18:223-232.
18. Nicolay JP, Gatz S, Liebig G, Gulbins E, Lang F: Amyloid induced suicidal erythrocyte death. Cell Physiol Biochem 2007;19:175-184.
19. Lang PA, Huober J, Bachmann C, Kempe DS, Sobiesiak M, Akel A, Niemoeller OM, Dreischer P, Eisele K, Klarl BA, Gulbins E, Lang F, Wieder T: Stimulation of erythrocyte phosphatidylserine exposure by paclitaxel. Cell Physiol Biochem 2006;18:151-164.
20. Akel A, Hermle T, Niemoeller OM, Kempe DS, Lang PA, Attanasio P, Podolski M, Wieder T, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by chlorpromazine. Eur J Pharmacol 2006;532:11-17.
21. Niemoeller OM, Akel A, Lang PA, Attanasio P, Kempe DS, Hermle T, Sobiesiak M, Wieder T, Lang F: Induction of eryptosis by cyclosporine. Naunyn Schmiedebergs Arch Pharmacol 2006;374:41-49.
22. Kempe DS, Lang PA, Eisele K, Klarl BA, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by lead ions. Am J Physiol Cell Physiol 2005;288:C396-C402.
23. Eisele K, Lang PA, Kempe DS, Klarl BA, Niemoller O, Wieder T, Huber SM, Duranton C, Lang F: Stimulation of erythrocyte phosphatidylserine exposure by mercury ions. Toxicol Appl Pharmacol 2005;
24. Arese P, Turrini F, Schwarzer E: Band 3/complement-mediated recognition and removal of normally senescent and pathological human erythrocytes. Cell Physiol Biochem 2005;16:133-146.
25. Barvitenko NN, Adragna NC, Weber RE: Erythrocyte signal transduction pathways, their oxygenation dependence and functional significance. Cell Physiol Biochem 2005;15:1-18.
26. Bosman GJ, Willekens FL, Werre JM: Erythrocyte aging: a more than superficial resemblance to apoptosis? Cell Physiol Biochem 2005;16:1-8.
27. Rice L, Alfrey CP: The negative regulation of red cell mass by neocytolysis: physiologic and pathophysiologic manifestations. Cell Physiol Biochem 2005;15:245-250.
28. Cohen CJ, Spires S, Van Skiver D: Block of T-type Ca channels in guinea pig atrial cells by antiarrhythmic agents and Ca channel antagonists. J Gen Physiol 1992;100:703-728.
29. Nishimura M, Follmer CH, Singer DH: Amiodarone blocks calcium current in single guinea pig ventricular myocytes. J Pharmacol Exp Ther 1989;251:650-659.
30. Pecini R, Elming H, Pedersen OD, Torp-Pedersen C: New antiarrhythmic agents for atrial fibrillation and atrial flutter. Expert Opin Emerg Drugs 2005;10:311-322.
31. Shinagawa K, Shiroshita-Takeshita A, Schram G, Nattel S: Effects of antiarrhythmic drugs on fibrillation in the remodeled atrium: insights into the mechanism of the superior efficacy of amiodarone. Circulation 2003;107:1440-1446.
32. Yamashita N, Kaku T, Uchino T, Isomoto S, Yoshimatsu H, Ono K: Short- and longterm amiodarone treatments regulate Cav3.2 low-voltage-activated T-type Ca2+ channel through distinct mechanisms. Mol Pharmacol 2006;69:1684-1691.
33. Arpin MP, Alt M, Kheiralla JC, Chabrier G, Welsch M, Imbs JL, Imler M: [Hyperthyroidism and immune hemolytic anemia following amiodarone therapy]. Rev Med Interne 1991;12:309-311.
34. Mohamed T, Sanjay R, Sycheva T, Aish L, Schneider D, Oo TH: Amiodarone-associated bone marrow granulomas: a report of 2 cases and review of the literature. Int J Hematol 2007;85:101-104.
35. Kodama I, Kamiya K, Toyama J: Cellular electropharmacology of amiodarone. Cardiovasc Res 1997;35:13-29.
36. Kodama I, Kamiya K, Toyama J: Amiodarone: ionic and cellular mechanisms of action of the most promising class III agent. Am J Cardiol 1999;84:20R-28R.
37. Waldhauser KM, Torok M, Ha HR, Thomet U, Konrad D, Brecht K, Follath F, Krahenbuhl S: Hepatocellular toxicity and pharmacological effect of amiodarone and amiodarone derivatives. J Pharmacol Exp Ther 2006;319:1413-1423.
38. Bargout R, Jankov A, Dincer E, Wang R, Komodromos T, Ibarra-Sunga O, Filippatos G, Uhal BD: Amiodarone induces apoptosis of human and rat alveolar epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 2000;278:L1039-L1044.
39. Choi IS, Kim BS, Cho KS, Park JC, Jang MH, Shin MC, Jung SB, Chung JH, Kim CJ: Amiodarone induces apoptosis in L-132 human lung epithelial cell line. Toxicol Lett 2002;132:47-55.
40. Isomoto S, Kawakami A, Arakaki T, Yamashita S, Yano K, Ono K: Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells. J Pharmacol Sci 2006;101:318-324.
41. Piccotti JR, LaGattuta MS, Knight SA, Gonzales AJ, Bleavins MR: Induction of apoptosis by cationic amphiphilic drugs amiodarone and imipramine. Drug Chem Toxicol 2005;28:117-133.
42. Kishida S, Nakajima T, Ma J, Jo T, Imuta H, Oonuma H, Iida H, Takano H, Morita T, Nagai R: Amiodarone and N-desethylamiodarone enhance endothelial nitric oxide production in human endothelial cells. Int Heart J 2006;47:85-93.
43. Andree HA, Reutelingsperger CP, Hauptmann R, Hemker HC, Hermens WT, Willems GM: Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. J Biol Chem 1990;265:4923-4928.
44. Lang PA, Kempe DS, Myssina S, Tanneur V, Birka C, Laufer S, Lang F, Wieder T, Huber SM: PGE(2) in the regulation of programmed erythrocyte death. Cell Death Differ 2005;12:415-428.
45. Heger JJ, Solow EB, Prystowsky EN, Zipes DP: Plasma and red blood cell concentrations of amiodarone during chronic therapy. Am J Cardiol 1984;53:912-917.
46. Roden DM: Pharmacokinetics of amiodarone: implications for drug therapy. Am J Cardiol 1993;72:45F-50F.
47. Veronese ME, McLean S, Hendriks R: Plasma protein binding of amiodarone in a patient population: measurement by erythrocyte partitioning and a novel glass-binding method. Br J Clin Pharmacol 1988;26:721-731.
48. Nattel S: The molecular and ionic specificity of antiarrhythmic drug actions. J Cardiovasc Electrophysiol 1999;10:272-282.
49. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM: A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature 2000;405:85-90.